430685
ÆóÒµÏà¹Ø»î¶¯¡¢·¢Õ¹¶¯Ì¬¡¢ÖØ´óʼþ¡¢Áìµ¼½²»°¡¢²úÆ··¢²¼¡¢Êг¡²ßÂÔµÈÄÚÈÝ
¡¡¡¡ÒÔ¡°¹ÄÀøÑ§ÕßʹÓùú²úÒÇÆ÷·¢±í¸ßˮƽÎÄÕ£¬¹²Í¬Íƶ¯Ãñ×å¿ÆÑ§½ø²½¡±ÎªÄ¿µÄµÄ2022Äê¶ÈÌÚÁú¼¯ÍŹÙÍø¡°ÎÞÏÞÑ»·¡±ÂÛÎĽ±Àø»î¶¯Ô²Âú½áÊø¡£¾ÆÀÒé£¬ÌÆ¿ª³ÇµÈ12λÓÅÐã×÷ÕßʹÓÃÌÚÁú¼¯ÍŹÙÍøÒÇÆ÷·¢±íÁ˸ßˮƽÂÛÎÄ£¬½«»ñµÃ±¾Äê¶ÈÂÛÎĽ±½ð¡£
¡¡¡¡ÉÏÊöͶ¸åÂÛÎÄÖУ¬BÀàÒ»Çø7ƪ£¬BÀà¶þÇø5ƪ£¬Ó°ÏìÒò×ÓÔÚ10ÒÔÉϵĹ²4ƪ£¬¹«Ë¾¶Ô¸÷λ×÷ÕßÈ¡µÃµÄ¹¤×÷³É¹û±íʾףºØ£¬¶ÔʼÖÕÖ§³Ö¹ú²ú¿ÆÑ§ÒÇÆ÷µÄ¿ÆÑй¤×÷ÕßÃDZíʾÓÉÖԵĸÐл£¬×£Ô¸¸÷λÐÂÄê¿ìÀÖ£¬ãؼÒÐÒ¸££¬Ò²×£Ô¸´ó¼ÒÔÚ¿ÆÑ§Ñо¿µÄÂþÂþÕ÷;ÖÐÈ¡µÃ¸ü¶àÊÕ»ñ¡£
¡¡¡¡¡°ÎÞÏÞÑ»·¡±ÂÛÎĽ±Àø»î¶¯ÎªÌÚÁú¼¯ÍŹÙÍøÃ¿Äê¶ÈÀýÐл£¬2022Äê»î¶¯½áÊøºó£¬2023Äê¶ÈÌÚÁú¼¯ÍŹÙÍøÂÛÎĽ±Àø»î¶¯Í¶¸åͨµÀ¼´½«¿ªÆô£¬´ó¼Ò¿ÉÒÔ¹Ø×¢ÌÚÁú¼¯ÍŹÙÍø¹Ù·½¹«Öںţ¬¼°Ê±Á˽â»î¶¯¶¯Ì¬£¬Ò²¿ÉÒÔÖµç0574-88350052Á˽âÏêÇé¡£
ºÃÎÄ·ÖÏí
¡¡¡¡ÀîÁˆÍŶÓ(Î÷ÄÏ´óѧ)ÓÚ2021ÄêÔÚ¡¶Advanced Functional Materials¡·ÆÚ¿¯Öз¢±íÁËÒ»ÖÖ»ùÓÚAMPÑ¡ÔñÐԵġ°Ç׺͹ýÂË¡±´«µÝ²ßÂÔ£¬ÊµÏÖ¸ü¾«×¼µÄ°ÐÏò²¡ÔÌåÑо¿³É¹û£ºAugmenting the Precise Targeting of Antimicrobial Peptides (AMPs) and AMP-Based Drug Delivery via Affinity-Filtering Strategy¡£
¡¡¡¡Ç׺͹ýÂ˲ßÂÔÊÇÔÚAMPÉÏÉè¼ÆÁËÒ»¸öÔ¤ÑڱΡ°¹ýÂËÆ÷¡±Ä£¿é£¬Í¨¹ýºìϸ°ûĤ°ÐÏò²¿·Ö£¬¹æ±ÜÁ˸´ÔÓÉúÀí»·¾³µÄ¸ÉÈÅ£¬²¢ÓÉÓÚÓ벡ÔÌåĤµÄ¶ÀÌØÇ׺ÍÐÔ¶øÊµÏÖÏìÓ¦ÐÔʶ±ð¡£Ñо¿±íÃ÷£º¾ßÓÐÇ׺͹ýÂ˵ÄampÐÞÊÎÄÉÃ׿ÅÁ£±íÏÖ³ö½µµÍµÄÍѰж¾ÐÔ£¬ÓëÄ¿±ê²¡ÔÌåµÄ³ä·Ö½áºÏ£¬ÒÔ¼°½«21ÌìÉú´æÂÊ´Ó30%(´«Í³ÔØÒ©ÄÉÃ׿ÅÁ£)ÏÔÖøÌá¸ßµ½70%¡£×îºóµÃ³ö½áÂÛ£º¸Ã²ßÂÔ¿ÉΪ¿Ë·þÒ©Îï°ÐÏòÖÎÁÆÖеÄÍѰÐЧӦÌṩÆô·¢£¬½øÒ»²½´Ù½øampµÄÁÙ´²Ó¦Óá£
¡¡¡¡ÐÂÖ¥Ïà¹ØÉ豸£ºSCIENTZ-950EÖÇÄܳ¬Éù²¨Ï¸°û·ÛËé»ú(PS-Ö¬ÖÊÌåÖÆ±¸)
¡¡¡¡¡÷ͼ1£º¿¹·Î²¿Õæ¾ú¸ÐȾµÄÇ׺͹ýÂ˲ßÂÔʾÒâͼ A)½«¿¹¾úëÄÐÞÊεÄÄÉÃ׿ÅÁ£Àι̵ØÃª¶¨ÔÚºìϸ°ûÉÏ£¬Í¬²½¿¹¾úëÄÒ²±»Ç¶Èëϸ°ûĤ B)¾¿¹¾úëÄÐÞÊεÄÄÉÃ׿ÅÁ£ÓÐЧ¹ýÂ˷ǰÐλµã£¬²¢Í¨¹ýÇ׺͹ýÂ˲ßÂÔ¾«È·µÝËÍÖÁÕæ¾ú¡£
¡¡¡¡ÕÅÖ¾¸ÕÍŶÓ(¶«±±Å©Òµ´óѧ)ÓÚ2022ÄêÔÚ¡¶Journal of Hazardous Materials¡·ÆÚ¿¯Öз¢±íÁËàç³æßø(THI)±©Â¶¶ÔÈÕ±¾ðÆðÈ΢ÉúÎï-³¦-¸ÎÖáÓ°ÏìµÄÑо¿³É¹û£ºEffects of thiacloprid exposure on microbiota-gut-liver axis: Multiomics mechanistic analysis in Japanese quails¡£
¡¡¡¡±¾Ñо¿Ö¼ÔÚ̽ÌÖTHI±©Â¶ÊÇ·ñͨ¹ý¸Ä±ä³¦µÀ¾úȺ¼°Ïà¹Ø´úлÎï´Ù½ø¸ÎËðÉË£¬Ëü²ÉÓöà×éѧ·½·¨·ÖÎöTHI¶ÔÈÕ±¾ðÆðȵ;ÐÔ»úÖÆ¡£Ñо¿±íÃ÷£ºTHI»áÒýÆð³¦ÆÁÕϹ¦ÄܵÄËðÉËºÍÆÆ»µ£¬µ¼Ö½øÈë¸ÎÔàµÄÖ¬¶àÌÇ(Lipopolysaccharide£¬LPS)ºÍ±½ÒÒËáµÈÓк¦ÎïÖÊÔö¼Ó¡£´ËÍ⣬½«ÊµÑé×éÓë¶ÔÕÕ×éÏà±È£¬THI±©Â¶ðÆðȵĸÎÔ൨ÖËáºÍµ¨¹Ì´¼´úлÏÔÖø¸Ä±ä£¬¸ÎÔàÖ¬ÖÊ´úлÒì³££¬±íÏÖ³öÑÏÖØµÄ¸ÎÔàËðÉË¡¢ÏËά»¯ºÍÖ¬·¾±äÐÔ¡£×îºóµÃ³ö½áÂÛ£ºTHI±©Â¶»áͨ¹ý΢ÉúÎï-³¦-¸ÎÖá¼ÓÖØ¸ÎÔàËðÉË¡£
¡¡¡¡ÐÂÖ¥Ïà¹ØÉ豸£ºSCIENTZ¨C48L¸ßͨÁ¿×éÖ¯ÑÐÄ¥Æ÷(»Ø³¦×éÖ¯µÄÑÐÄ¥´¦Àí)
¡¡¡¡¡÷ͼ2 THI¶ÔðÆðȸÎÔàת¼×éµÄÓ°Ï죨n = 5£©£»£¨A£©Óë¶ÔÕÕ×éÏà±È£¬THI±©Â¶ðÆðȳ¦µÀ×éÖ¯ÖÐDEGsµÄ¿ÉÊÓ»¯£»£¨B£©´ÓTHI-H×éµ½¶ÔÕÕ×éµÄKEGG¸»¼¯·ÖÎö£»£¨C£©´ÓTHI-Hµ½¶ÔÕÕ×éµÄGO·Ö¼¶
¡¡¡¡Ëï½øÍŶÓ(ÉòÑôÒ©¿Æ´óѧ)ÓÚ2022ÄêÔÚ¡¶Nano Letters¡·ÆÚ¿¯Öз¢±íÁËÀûÓÃϸ°ûÍâÄÒÅÝ·ÖÃڴ̼¤¼ÁÓëĤÈÚºÏÏà½áºÏ²ßÂÔ£¬´Ó¶ø´ïµ½´Ù½øÄÉÃ×Ò©ÎïµÄÖ×ÁöÉøÍ¸ÂʵÄÑо¿³É¹û£ºMonensin Enhanced Generation of Extracellular Vesicles as Transfersomes for Promoting Tumor Penetration of Pyropheophorbide-a from Fusogenic Liposome¡£
¡¡¡¡ÀûÓÃË®»¯±¡Ä¤·ÖÉ¢·¨¹¹½¨Ò»¸öϸ°ûÍâÄÒÅÝ(EVs)½éµ¼µÄ×ÔÍÆ½øÄÜÖ¬ÖÊÌ壬°üº¬×÷Ϊ¿É³ÖÐøÖúÍÆ¼ÁµÄĪÄܾúËØ(Mon)ºÍ×÷Ϊ¹âÃô¼ÁµÄPPa¡£Ñо¿±íÃ÷£ºMonºÍPPaÊ×ÏÈÔÚĤÈÚºÏÖ¬ÖÊÌåµÄ°ïÖúÏÂ×ªÒÆµ½Ö×ÁöÖÊĤÉÏ£¬È»ºó±»°ü×°µ½Ï¸°ûÍâÄÒÅÝÖУ¬ÓÉÍâ²ãÖ×Áöϸ°û·ÖÃÚµÄÄÚÔ´ÐÔϸ°ûÍâÄÒÅÝ¿ÉÒԽ鵼MonºÍPPaµÄϸ°û¼ä´«µÝ¡£ÌرðÊÇMon×÷ΪһÖֿɳÖÐøµÄÖúÍÆÆ÷£¬¿ÉÒԴ̼¤Ï¸°ûÍâÄÒÅݵÄÊÍ·Å£¬ÏÔÖø·Å´óÁËEVs½éµ¼µÄPPaÉøÍ¸¡£×îºóµÃ³ö½áÂÛ£ºÕâÖÖÄÚÔ´ÐÔϸ°ûÍâÄÒÅݵÄÄÉÃׯ½Ì¨¿ÉÒÔÌáÉýÖ×ÁöµÄÉî¶È´©Í¸ºÍÔöÇ¿¹âÖÎÁÆÐ§¹û¡£
¡¡¡¡ÐÂÖ¥Ïà¹ØÉ豸£ºSCIENTZ-IID³¬Éù²¨Ï¸°û·ÛËé»ú(¹²ÔØMonºÍPPaµÄĤÈÚºÏÖ¬ÖÊÌåÖÆ±¸)
¡¡¡¡¡÷ͼ3£º(A) MFL/PPa+MonµÄÖÆ±¸£»(B) ϸ°ûÍâÄÒÅݽ鵼µÄϸ°û¼äÇ¨ÒÆºÍÖ×ÁöÉøÍ¸£»(C) ĪÄܾúËØ´Ì¼¤¸ºÔØPPaµÄϸ°ûÍâÄÒÅݵķÖÃÚ
ÉÏһƪ£º 2024Äê¶ÈÐÂÖ¥ÂÛÎĽ±Àø»î¶¯½á¹û¹«Ê¾
ÏÂһƪ£º 2021Äê¶ÈÌÚÁú¼¯ÍŹÙÍøÂÛÎĽ±Àø»î¶¯
24Сʱ·þÎñÈÈÏß 18106650612